Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/aktuelle-indikationsstellung-zur-vorhofohrokkluderimplantation-774uJavk0P
References (43)
-
SJ Lee, JH Sung, JB Kim, MS Ahn, HY Lee, JS Uhm, HN Pak, MH Lee, JY Kim, B Joung (2016)
The safety and efficacy of vitamin K antagonist in atrial fibrillation patients with previous ulcer bleeding: long-term results from a multicenter studyMedicine (Baltimore), 95
-
DR Holmes, SK Doshi, S Kar, MJ Price, JM Sanchez, H Sievert, M Valderrabano, VY Reddy (2015)
Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysisJ Am Coll Cardiol, 65
-
G Ailawadi, MW Gerdisch, RL Harvey (2011)
Exclusion of the left atrial appendage with a novel device: early results of a multicenter trialJ Thorac Cardiovasc Surg, 142
-
MY Emmert, G Puippe, S Baumüller, H Alkadhi, U Landmesser, A Plass, D Bettex, J Scherman, J Grünenfelder, M Genoni, V Falk, SP Salzberg (2014)
Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trialEur J Cardiothorac Surg, 45
-
DM Witt, T Delate, DA Garcia, NP Clark, EM Hylek, W Ageno, F Dentali, MA Crowther (2012)
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleedingArch Intern Med, 172
-
A Arboix, J Alio (2012)
Acute cardioembolic cerebral infarction: answers to clinical questionsCurr Cardiol Rev, 8
-
AJ Grau, C Weimar, F Buggle (2001)
Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bankStroke, 32
-
VY Reddy, RL Akehurst, SO Armstrong, SL Amorosi, N Brereton, DS Hertz, DR Holmes (2016)
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarinEuropace, 18
-
HJ Lin, PA Wolf, M Kelly-Hayes, AS Beiser, CS Kase, EJ Benjamin, RB D’Agostino (1996)
Stroke severity in atrial fibrillation. The Framingham StudyStroke, 27
-
B Meier, Y Blaauw, AA Khattab, T Lewalter, H Sievert, C Tondo, M Glikson (2014)
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusionEuropace, 16
-
DR Holmes, VY Reddy, ZG Turi, SK Doshi, H Sievert, M Buchbinder, CM Mullin, P Sick (2009)
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trialLancet, 374
-
V Sjögren, B Byström, H Renlund, PJ Svensson, J Oldgren, B Norrving, A Själander (2017)
Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: a retrospective register studyPLOS ONE, 12
-
X Yao, NS Abraham, GC Alexander, W Crown, VM Montori, LR Sangaralingham, BJ Gersh, ND Shah, PA Noseworthy (2016)
Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillationJ Am Heart Assoc, 23
-
ML Hansen, R Sørensen, MT Clausen, ML Fog-Petersen, J Raunsø, N Gadsbøll, GH Gislason, F Folke, SS Andersen, TK Schramm, SZ Abildstrøm, HE Poulsen, L Køber, C Torp-Pedersen (2010)
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillationArch Intern Med, 170
-
BA Steinberg, MA Greiner, BG Hammill, LH Curtis, EJ Benjamin, SR Heckbert, JP Piccini (2015)
Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillationCardiovasc Ther, 33
-
P Kirchhof, S Benussi, D Kotecha, A Ahlsson, D Atar, B Casadei, M Castella, HC Diener, H Heidbuchel, J Hendriks, G Hindricks, AS Manolis, J Oldgren, BA Popescu, U Schotten, B Putte, P Vardas, S Agewall, J Camm, G Baron Esquivias, W Budts, S Carerj, F Casselman, A Coca, R Caterina, S Deftereos, D Dobrev, JM Ferro, G Filippatos, D Fitzsimons, B Gorenek, M Guenoun, SH Hohnloser, P Kolh, GY Lip, A Manolis, J McMurray, P Ponikowski, R Rosenhek, F Ruschitzka, I Savelieva, S Sharma, P Suwalski, JL Tamargo, CJ Taylor, IC Gelder, AA Voors, S Windecker, JL Zamorano, K Zeppenfeld (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEuropace, 18
-
H Schelleman, CM Brensinger, WB Bilker, S Hennessy (2011)
Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control studyPLOS ONE, 6
-
SJ Lee, DH Shin, HJ Hwang, JY Kim, HN Pak, MH Lee, B Joung (2012)
Bleeding risk and major adverse events in patients with previous ulcer on oral anticoagulation therapyAm J Cardiol, 110
-
R Hart, L Pearce, M Aguilar (2007)
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med, 146
-
LV Boersma, H Ince, S Kische, E Pokushalov, T Schmitz, B Schmidt, T Gori, F Meincke, AV Protopopov, T Betts, D Foley, H Sievert, P Mazzone, T Potter, E Vireca, K Stein, MW Bergmann (2017)
Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1‑Year follow-up outcome data of the EWOLUTION trialHeart Rhythm, 14
-
GC Jickling, B Stamova, BP Ander (2012)
Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct locationStroke, 43
-
SH Lee, JY Cho, HJ Joo, JH Park, S Hong, CW Yu, DS Lim (2016)
A comparison of clinical outcomes between triple antithrombotic therapy versus dual antiplatelet with left atrial appendage occlusion in patients with atrial fibrillation undergoing drug-eluting stent implantationJ Am Coll Cardiol, 68
-
S Panikker, JW Jarman, R Virmani, R Kutys, S Haldar, E Lim, C Butcher, H Khan, L Mantziari, E Nicol, JP Foran, V Markides, T Wong (2016)
Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: a first-in-human safety, feasibility, and efficacy studyCirc Arrhythm Electrophysiol, 9
-
JM Lee, J Shim, JS Uhm, YJ Kim, HJ Lee, HN Pak, MH Lee, B Joung (2014)
Impact of increased orifice size and decreased flow velocity of left atrial appendage on stroke in nonvalvular atrial fibrillationAm J Cardiol, 113
-
HT Tu, BC Campbell, S Christensen, M Collins, DA Silva, KS Butcher, MW Parsons, PM Desmond, PA Barber, CR Levi, CF Bladin, GA Donnan, SM Davis (2010)
Pathophysiological determinants of worse stroke outcome in atrial fibrillationCerebrovasc Dis, 30
-
A Rillig, RR Tilz, T Lin, T Fink, CH Heeger, A Arya, A Metzner, S Mathew, E Wissner, H Makimoto, P Wohlmuth, KH Kuck, F Ouyang (2016)
Unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmiasCirc Arrhythm Electrophysiol, 9
-
JL Blackshear, JA Odell (1996)
Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillationAnn Thorac Surg, 61
-
LL Demer, Y Tintut, F Parhami (2002)
Novel mechanisms in accelerated vascular calcification in renal disease patientsCurr Opin Nephrol Hypertens, 11
-
DR Holmes, VY Reddy, M Buchbinder, K Stein, M Elletson, MW Bergmann, B Schmidt, J Saw (2017)
The assessment of the Watchman device in patients unsuitable for oral Anticoagulation (ASAP-TOO) trialAm Heart J, 189
-
VY Reddy, SK Doshi, H Sievert, M Buchbinder, P Neuzil, K Huber, JL Halperin, D Holmes (2013)
Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) TrialCirculation, 127
-
K Bartus, FT Han, J Bednarek, J Myc, B Kapelak, J Sadowski, J Lelakowski, S Bartus, SJ Yakubov, RJ Lee (2013)
Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experienceJ Am Coll Cardiol, 62
-
M Lempereur, A Aminian, X Freixa, S Gafoor, S Shakir, H Omran, S Berti, G Santoro, J Kefer, U Landmesser, JE Nielsen-Kudsk, I Cruz-Gonzalez, P Kanagaratnam, F Nietlispach, R Ibrahim, H Sievert, W Schillinger, JW Park, S Gloekler, A Tzikas (2017)
Left atrial appendage occlusion in patients with atrial fibrillation and previous major gastrointestinal bleeding (from the Amplatzer Cardiac Plug Multicenter Rregistry)Am J Cardiol, 120
-
DR Holmes, S Kar, MJ Price, B Whisenant, H Sievert, SK Doshi, K Huber, VY Reddy (2014)
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trialJ Am Coll Cardiol, 64
-
W Qureshi, C Mittal, I Patsias, K Garikapati, A Kuchipudi, G Cheema, M Elbatta, Z Alirhayim, F Khalid (2014)
Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillationAm J Cardiol, 113
-
D Lakkireddy, MR Afzal, RJ Lee, H Nagaraj, D Tschopp, B Gidney, C Ellis, E Altman, B Lee, S Kar, N Bhadwar, M Sanchez, V Gadiyaram, R Evonich, A Rasekh, J Cheng, F Cuoco, S Chandhok, S Gunda, M Reddy, D Atkins, S Bommana, P Cuculich, D Gibson, J Nath, R Ferrell, E Matthew, D Wilber (2016)
Short and long-term outcomes of percutaneous left atrial appendage suture ligation: results from a US multicenter evaluationHeart Rhythm, 13
-
VY Reddy, S Möbius-Winkler, MA Miller, P Neuzil, G Schuler, J Wiebe, P Sick, H Sievert (2013)
Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)J Am Coll Cardiol, 61
-
A Tzikas, S Shakir, S Gafoor, H Omran, S Berti, G Santoro, J Kefer, U Landmesser, JE Nielsen-Kudsk, I Cruz-Gonzalez, H Sievert, T Tichelbäcker, P Kanagaratnam, F Nietlispach, A Aminian, F Kasch, X Freixa, P Danna, M Rezzaghi, P Vermeersch, F Stock, M Stolcova, M Costa, R Ibrahim, W Schillinger, B Meier, JW Park (2016)
Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plugEuroIntervention, 11
-
A Tzikas, DR Holmes, S Gafoor, CE Ruiz, C Blomström-Lundqvist, HC Diener, R Cappato, S Kar, RJ Lee, RA Byrne, R Ibrahim, D Lakkireddy, OI Soliman, M Nabauer, S Schneider, J Brachmann, JL Saver, K Tiemann, H Sievert, AJ Camm, T Lewalter (2017)
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studiesEuropace, 19
-
CT Ruff, RP Giugliano, E Braunwald, EB Hoffman, N Deenadayalu, MD Ezekowitz, AJ Camm, JI Weitz, BS Lewis, A Parkhomenko, T Yamashita, EM Antman (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsLancet, 383
-
EC O’Brien, DN Holmes, JE Ansell, LA Allen, E Hylek, PR Kowey, BJ Gersh, GC Fonarow, CR Koller, MD Ezekowitz, KW Mahaffey, P Chang, ED Peterson, JP Piccini, DE Singer (2014)
Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAm Heart J, 167
-
JE Nielsen-Kudsk, SP Johnsen, P Wester, D Damgaard, J Airaksinen, J Lund, O Backer, S Pakarinen, J Odenstedt, S Vikman, M Settergren, O Kongstad, M Rosenqvist, DW Krieger (2017)
Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up studyEuroIntervention, 13
-
AK Kakkar, I Mueller, JP Bassand, DA Fitzmaurice, SZ Goldhaber, S Goto, S Haas, W Hacke, GY Lip, LG Mantovani, AG Turpie, M Eickels, F Misselwitz, S Rushton-Smith, G Kayani, P Wilkinson, FW Verheugt, GARFIELD Registry Investigators (2013)
Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registryPLOS ONE, 8
-
K Fukushima, N Fukushima, K Kato, K Ejima, H Sato, K Fukushima, C Saito, K Hayashi, K Arai, T Manaka, K Ashihara, M Shoda, N Hagiwara (2016)
Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillationEur Heart J Cardiovasc Imaging, 17
- Publisher
- Springer Journals
- Copyright
- Copyright © 2017 by Springer Medizin Verlag GmbH
- Subject
- Medicine & Public Health; Cardiology
- ISSN
- 0938-7412
- eISSN
- 1435-1544
- DOI
- 10.1007/s00399-017-0531-1
- Publisher site
- See Article on Publisher Site
Abstract
Das Blutungsrisiko steigt mit dem Schlaganfallrisiko bei Patienten mit Vorhofflimmern. Okkluder des linken Vorhofohrs (LAA) erlauben, die Blutungsrate bei Risikopatienten zu senken. Ausgehend von einer Datenanalyse und des Konsensus-Dokuments der European Heart Rhythm Association (EHRA) werden die Indikationen für einen LAA-Okkluder beleuchtet und in einem klaren Schema für den klinischen Alltag präsentiert.
Journal
Herzschrittmachertherapie + Elektrophysiologie – Springer Journals
Published: Oct 25, 2017